drugset / Trial / NCT00252122
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcotics).
Timeline
- Start
- 2004-06
- Primary completion
- 2005-11
- Completion
- 2007-01
Outcome
Outcome not reported
Stopped (Enrollment): “Recruitment was very slow.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.2 mg/kg | Intravenous |